What we've found so far is that the evidence we've reviewed leans toward oral sesaminol supplementation increasing butyric acid and other short-chain fatty acids in the guts of mice exposed to chronic ethanol [1]. Our analysis of the available research suggests this effect may be linked to improvements in gut health and reduced inflammation in these animals.
We analyzed one claim from the scientific literature, which reports that a small daily dose of sesaminol may help boost beneficial gut chemicals, including butyric acid, in mice that consume alcohol regularly [1]. Butyric acid is a type of short-chain fatty acid known for supporting gut barrier function and regulating inflammation. The evidence indicates that sesaminol might help maintain healthier levels of these compounds despite chronic ethanol exposure, which typically disrupts gut microbiota and reduces short-chain fatty acid production.
Our current analysis shows that all six supporting studies point in the same direction, with no studies found that refute this effect [1]. However, we emphasize that this is a limited body of evidence—only one claim has been analyzed so far, even if it draws from six supporting studies. We do not know the quality, size, or methods of those studies, so we cannot assess how strong the findings are.
Because the data is limited to animal models and focused on a single claim, we cannot say whether this effect would occur in humans or what the right dose might be. Also, we have not reviewed any long-term safety data or potential side effects.
Practical takeaway: In mice that drink alcohol regularly, sesaminol might help protect the gut by boosting beneficial chemicals like butyric acid—but this is early evidence, and we need more data before drawing firm conclusions.
2 items of evidenceView full answer